glp-1 receptor agonist function Science Behind GLP 1 GIP and Glucagon Agonists for Obesity Research | News & Announcements Major physiological roles of GLP-1

The takeaway

First-line therapies, including metformin, sodium-glucose cotransporter-2 inhibitors (SGLT-2i), and Glucagon-like peptide-1 (GLP-1) receptor agonists, are selected according to patient-specific risk factors

When I got there, the question was what was I going to do, what was my project going to be? Raufman recalls

studies have shown a significant portion of patients lose less than 5% of their body weight on the drug, though they may experience other metabolic improvements

The current study Study author Yuya Koide and his colleagues wanted to explore how individuals with type 2 diabetes respond to GLP-1RAs therapy (Koide et al., 2025)